Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients

NCT01560169 is registered in ClinicalTrials.gov with Alvine Pharmaceuticals Inc. as lead sponsor.

NCT NCT01560169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01560169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Three Celiac Disease-Specific Patient Reported Outcome Instruments in Established and Newly Diagnosed Celiac Disease Patients
Lead sponsor
Alvine Pharmaceuticals Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2012
Completion date
September 30, 2013
Enrollment
110 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease